drugset / Trial / NCT05989997
Phase I Clinical Trial of 68Ga-NOTA-SNA002
NaSingle-groupOpen-labelDiagnostic
Summary
The clinical trial was a single-center, dose-increasing, open trial.In this clinical trial, 68Ga-NOTA-SNA002 was injected intravenously to observe its safety tolerance, radiation absorption dose, distribution characteristics, etc. in patients with solid tumors.
Timeline
- Start
- 2023-11-01
- Primary completion
- 2024-11-08
- Completion
- 2024-11-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 68Ga-NOTA-SNA002 | Unknown | — | Intravenous |